normal phenotype
• appeared normal and indistinguishable from wild-type
|
Allele Symbol Allele Name Allele ID |
Mapk14tm1.2Otsu targeted mutation 1.2, Kinya Otsu MGI:3525576 |
||||||||||||||||||||
Summary |
4 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• appeared normal and indistinguishable from wild-type
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• performance on the rotarod is similar to controls, although there is a slight trend toward improved performance
|
• resistant to agonist U50,488-induced conditioned place aversion (CPA)
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• 30% of mutants died one week after TAC induced pressure overload compared to 8% in controls
|
• heart was larger than in controls after TAC induced pressure overload or adrenergic stimulation
|
• heart weight, left ventricle weight, and average ratio of left ventricle weight to tibial length or body weight were significantly greater than in controls after TAC induced pressure overload, however no difference in cardiomyocyte cell area was observed
|
• observed intermuscular and perivascular fibrosis in mutants compared to only slight perivascular fibrosis in controls after TAC induced pressure overload
|
• mice exhibit normal cardiac function and structure under baseline conditions, however cardiac contractility was significantly reduced after thoracic transverse aortic constriction (TAC) induced pressure overload and chronic adrenergic stimulation
|
• increased left ventricle end-diastolic and end-systolic diameters compared to controls after TAC induced pressure overload
|
• after TAC induced pressure overload, exhibit greater increases in mortality, heart size and weight, cardiac fibrosis, and cardiomyocyte apoptosis and decreased cardiac contractility compared to controls
|
• mice exhibit normal cardiac function and structure under baseline conditions, however cardiac contractility was significantly reduced after thoracic transverse aortic constriction (TAC) induced pressure overload and chronic adrenergic stimulation
|
• increased left ventricle end-diastolic and end-systolic diameters compared to controls after TAC induced pressure overload
|
• the number of apoptotic cardiac myocytes was 3.7 times that in controls after TAC induced pressure overload and was also increased in response to chronic adrenergic stimulation
|
• after TAC induced pressure overload, exhibit greater increases in mortality, heart size and weight, cardiac fibrosis, and cardiomyocyte apoptosis and decreased cardiac contractility compared to controls
|
• the number of apoptotic cardiac myocytes was 3.7 times that in controls after TAC induced pressure overload and was also increased in response to chronic adrenergic stimulation
|
• heart was larger than in controls after TAC induced pressure overload or adrenergic stimulation
|
• heart weight, left ventricle weight, and average ratio of left ventricle weight to tibial length or body weight were significantly greater than in controls after TAC induced pressure overload, however no difference in cardiomyocyte cell area was observed
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• at 6 months in male mice
|
• at 6 months in male mice
|
• narrow in male mice
|
• in male mice
|
• in male mice
|
• short at 6 months in male mice
|
• by 3 to 4 weeks in female and male mice
|
• in male and female mice
|
N |
• mice exhibit normal IGF1 serum levels
|
• at 6 months in male mice
|
• at 6 months in male mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|